Arthropathy of Knee
0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
StrykerMako Robotic-Arm Assisted Arthroplasty
StrykerTriathlon All-Polyethylene Tibia Knee
ExactechOptetrak PS
StrykerScorpio® CR Total Knee System
Clinical Trials (4)
Total enrollment: 1,369 patients across 4 trials
Mako-MORE Registry
Start: Jun 2026Est. completion: Mar 2037950 patients
N/ANot Yet Recruiting
Triathlon All-Polyethylene Tibia Outcomes Study
Start: Jul 2021Est. completion: Oct 2033204 patients
N/AActive Not Recruiting
Optetrak Posterior Stabilized Versus Optetrak Hi-Flex
Start: Dec 2008Est. completion: Jan 20120
N/AWithdrawn
Scorpio® Cruciate Retaining (CR) Outcomes Study
Start: Jun 2001215 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.